A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Summary

The primary objective of the study is to demonstrate that dupilumab treatment improves exercise capacity in patients with moderate-to-severe asthma. The secondary objectives of the study are: * To demonstrate that dupilumab treatment increases physical activity of daily living in patients with moderate-to-severe asthma * To demonstrate that dupilumab treatment improves pre- and post-exercise lung function in patients with moderate-to-severe asthma

Timeline

Start

2020-07-16

Primary completion

2023-07-15

Completion

2023-07-15

Drugs

Indications